Arid5a Mediates an IL-17–Dependent Pathway That Drives Autoimmunity but Not Antifungal Host Defense
Open Access
- 15 September 2022
- journal article
- research article
- Published by Oxford University Press (OUP) in The Journal of Immunology
- Vol. 209 (6) , 1138-1145
Abstract
IL-17 contributes to the pathogenesis of certain autoimmune diseases, but conversely is essential for host defense against fungi. Ab-based biologic drugs that neutralize IL-17 are effective in autoimmunity but can be accompanied by adverse side effects. Candida albicans is a commensal fungus that is the primary causative agent of oropharyngeal and disseminated candidiasis. Defects in IL-17 signaling cause susceptibility to candidiasis in mice and humans. A key facet of IL-17 receptor signaling involves RNA-binding proteins, which orchestrate the fate of target mRNA transcripts. In tissue culture models we showed that the RNA-binding protein AT-rich interaction domain 5A (Arid5a) promotes the stability and/or translation of multiple IL-17–dependent mRNAs. Moreover, during oropharyngeal candidiasis, Arid5a is elevated within the oral mucosa in an IL-17–dependent manner. However, the contribution of Arid5a to IL-17–driven events in vivo is poorly defined. In this study, we used CRISPR-Cas9 to generate mice lacking Arid5a. Arid5a−/− mice were fully resistant to experimental autoimmune encephalomyelitis, an autoimmune setting in which IL-17 signaling drives pathology. Surprisingly, Arid5a−/− mice were resistant to oropharyngeal candidiasis and systemic candidiasis, similar to immunocompetent wild-type mice and contrasting with mice defective in IL-17 signaling. Therefore, Arid5a-dependent signals mediate pathology in autoimmunity and yet are not required for immunity to candidiasis, indicating that selective targeting of IL-17 signaling pathway components may be a viable strategy for development of therapeutics that spare IL-17–driven host defense.Keywords
All Related Versions
Funding Information
- HHS | NIH | National Institute of Allergy and Infectious Diseases (AI144436, AI147383, AI142354, AI159058, AI089443, AI148356)
- HHS | NIH | National Institute of Dental and Craniofacial Research (DE022550)
This publication has 84 references indexed in Scilit:
- Gene set enrichment analysis of RNA-Seq data: integrating differential expression and splicingBMC Bioinformatics, 2013
- Induction and molecular signature of pathogenic TH17 cellsNature Immunology, 2012
- Mouse model of oropharyngeal candidiasisNature Protocols, 2012
- Treatment with IL-17 prolongs the half-life of chemokine CXCL1 mRNA via the adaptor TRAF5 and the splicing-regulatory factor SF2 (ASF)Nature Immunology, 2011
- New mechanism of oral immunity to mucosal candidiasis in hyper-IgE syndromeMucosal Immunology, 2011
- Chronic Mucocutaneous Candidiasis in Humans with Inborn Errors of Interleukin-17 ImmunityScience, 2011
- IL-17-induced NF-κB Activation via CIKS/Act1Journal of Biological Chemistry, 2011
- Th17 cells and IL-17 receptor signaling are essential for mucosal host defense against oral candidiasisJournal of Experimental Medicine, 2009
- The interleukin 23 receptor is essential for the terminal differentiation of interleukin 17–producing effector T helper cells in vivoNature Immunology, 2009
- Interleukin-23 rather than interleukin-12 is the critical cytokine for autoimmune inflammation of the brainNature, 2003